In adults with HIV and low-to-moderate CV risk, pitavastatin reduced MACE over a median 5.1 y.
Where this comes from
- Record sourced from PubMed, PMID 37931263.
- Also identified by DOI 10.7326/J23-0083.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Grinspoon SK, Fitch KV, Zanni MV, et al; REPRIEVE Investigators. <b>Pitavastatin to prevent cardiovascular disease in HIV infection.</b> N Engl J Med. 2023;389:687-699. 37486775.
Medical subject headings
- HIV Infections
- Quinolines
- Cardiovascular Diseases